MedX Health Corp. (MDXHF) vs Precipio, Inc. (PRPO)

MedX Health Corp. and Precipio, Inc. are both Diagnostics & Research companies. MedX Health Corp. is the larger, with a market value of $103.2M against $43.8M — 2.4× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against 9.96%. Precipio, Inc. has the higher net margin (−4.47% vs −1,095.0%) and the lower return on invested capital (−7.63% vs 0.00%). Across the 17 metrics below, Precipio, Inc. leads on 14 and MedX Health Corp. on 3.

Valuation

Metric MDXHF PRPO Diagnostics & Research median
P/E n/m n/m 33.95
P/S 25.16 1.55 4.87
P/B n/m 2.86 3.12
Price to free cash flow n/m 53.57 34.02
EV/EBITDA n/m 135.71 25.20
EV/Sales 30.65 1.48 5.66
Earnings yield (46.00%) (2.71%) (1.75%)
Free cash flow yield (55.11%) 1.87% (0.13%)

Profitability

Metric MDXHF PRPO Diagnostics & Research median
Gross margin (6.88%) 44.11% 50.89%
Operating margin (742.33%) (5.68%) (8.57%)
Net margin (1,094.99%) (4.47%) (6.37%)
Free cash flow margin (999.18%) 2.90% 0.00%
Return on equity 63.45% (8.98%) (2.92%)
Return on assets (867.29%) (6.05%) (6.71%)
Return on invested capital 0.00% (7.63%) 0.00%

Growth

Metric MDXHF PRPO Diagnostics & Research median
Revenue growth (TTM) 9.96% 28.04% 7.69%
EPS growth (last fiscal year) (52.00%) 92.15% —
Revenue growth, 5-year CAGR (55.05%) 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXHF PRPO Diagnostics & Research median
Debt to equity (0.32) 0.07 0.11
Current ratio 0.04 1.77 2.02
Net debt to EBITDA (0.40) (3.30) 0.78

Dividend

Metric MDXHF PRPO Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MDXHF PRPO Diagnostics & Research median
Market cap 103.16m 43.81m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack